Bae-Jump V - Search Results

1

Outpatient end of life discussions shorten hospital admissions in gynecologic oncology patients.

Doll KM, Stine JE, Van Le L, Moore DT, Bae-Jump V, Brewster WR, Soper JT, Boggess JF, Gehrig PA, Kim KH. Doll KM, et al. Gynecol Oncol. 2013 Jul;130(1):152-5. doi: 10.1016/j.ygyno.2013.03.020. Epub 2013 Mar 29. Gynecol Oncol. 2013. PMID: 23542684

2

Association between uterine serous carcinoma and breast cancer.

Gehrig PA, Bae-Jump VL, Boggess JF, Groben PA, Fowler WC Jr, Van Le L. Gehrig PA, et al. Gynecol Oncol. 2004 Jul;94(1):208-11. doi: 10.1016/j.ygyno.2004.04.009. Gynecol Oncol. 2004. PMID: 15262144

3

Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?

Boruta DM 2nd, Gehrig PA, Groben PA, Bae-Jump V, Boggess JF, Fowler WC Jr, Van Le L. Boruta DM 2nd, et al. Cancer. 2004 Nov 15;101(10):2214-21. doi: 10.1002/cncr.20645. Cancer. 2004. PMID: 15452833 Free article.

4

Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest.

Bae-Jump VL, Zhou C, Gehrig PA, Whang YE, Boggess JF. Bae-Jump VL, et al. Gynecol Oncol. 2006 Mar;100(3):487-94. doi: 10.1016/j.ygyno.2005.08.053. Epub 2005 Oct 24. Gynecol Oncol. 2006. PMID: 16249016

5

The PTEN tumor suppressor inhibits telomerase activity in endometrial cancer cells by decreasing hTERT mRNA levels.

Zhou C, Bae-Jump VL, Whang YE, Gehrig PA, Boggess JF. Zhou C, et al. Gynecol Oncol. 2006 May;101(2):305-10. doi: 10.1016/j.ygyno.2005.10.038. Epub 2005 Dec 27. Gynecol Oncol. 2006. PMID: 16380156

6

Estrogen-receptor-dependent regulation of telomerase activity in human endometrial cancer cell lines.

Boggess JF, Zhou C, Bae-Jump VL, Gehrig PA, Whang YE. Boggess JF, et al. Gynecol Oncol. 2006 Nov;103(2):417-24. doi: 10.1016/j.ygyno.2006.03.032. Epub 2006 May 11. Gynecol Oncol. 2006. PMID: 16690106

7

Cytological evaluation correlates poorly with histological diagnosis of vulvar neoplasias.

Bae-Jump VL, Bauer M, Van Le L. Bae-Jump VL, et al. J Low Genit Tract Dis. 2007 Jan;11(1):8-11. doi: 10.1097/01.lgt.0000229566.57482.f3. J Low Genit Tract Dis. 2007. PMID: 17194944

8

Induction of apoptosis and inhibition of telomerase activity by arsenic trioxide (As2O3) in endometrial carcinoma cells.

Zhou C, Boggess JF, Bae-Jump V, Gehrig PA. Zhou C, et al. Gynecol Oncol. 2007 Apr;105(1):218-22. doi: 10.1016/j.ygyno.2006.11.027. Epub 2007 Feb 2. Gynecol Oncol. 2007. PMID: 17275888

9

Outcomes in surgical stage I uterine papillary serous carcinoma.

Havrilesky LJ, Secord AA, Bae-Jump V, Ayeni T, Calingaert B, Clarke-Pearson DL, Berchuck A, Gehrig PA. Havrilesky LJ, et al. Gynecol Oncol. 2007 Jun;105(3):677-82. doi: 10.1016/j.ygyno.2007.01.041. Epub 2007 Mar 13. Gynecol Oncol. 2007. PMID: 17355889

10

The role of multi-modality adjuvant chemotherapy and radiation in women with advanced stage endometrial cancer.

Alvarez Secord A, Havrilesky LJ, Bae-Jump V, Chin J, Calingaert B, Bland A, Rutledge TL, Berchuck A, Clarke-Pearson DL, Gehrig PA. Alvarez Secord A, et al. Gynecol Oncol. 2007 Nov;107(2):285-91. doi: 10.1016/j.ygyno.2007.06.014. Epub 2007 Aug 6. Gynecol Oncol. 2007. PMID: 17688923

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters